Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
125.2 INR | +4.68% | +1.21% | +20.96% |
19/04 | Ind-Swift Laboratories to Incorporate Wholly-Owned Arm in Dubai | MT |
19/04 | Ind-Swift Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary | CI |
Sales 2022 | 10.52B 126M | Sales 2023 | 12.16B 146M | Capitalization | 3.26B 39.1M |
---|---|---|---|---|---|
Net income 2022 | -21M -252K | Net income 2023 | 476M 5.71M | EV / Sales 2022 | 1.26 x |
Net Debt 2022 | 9.32B 112M | Net Debt 2023 | 8.44B 101M | EV / Sales 2023 | 0.96 x |
P/E ratio 2022 |
-183
x | P/E ratio 2023 |
6.85
x | Employees | 1,496 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.86% |
1 day | +4.68% | ||
1 week | +1.21% | ||
Current month | +25.06% | ||
1 month | +24.50% | ||
3 months | +16.03% | ||
6 months | +44.63% | ||
Current year | +20.96% |
Managers | Title | Age | Since |
---|---|---|---|
Navrattan Munjal
CEO | Chief Executive Officer | 72 | 04/95/04 |
Himanshu Jain
CEO | Chief Executive Officer | 41 | - |
Gagan Aggarwal
DFI | Director of Finance/CFO | - | 29/18/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Himanshu Jain
CEO | Chief Executive Officer | 41 | - |
Navrattan Munjal
CEO | Chief Executive Officer | 72 | 04/95/04 |
Director/Board Member | 68 | 31/09/31 |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 125.2 | +4.68% | 276 458 |
30/24/30 | 119.6 | -1.89% | 376,914 |
29/24/29 | 122 | -2.40% | 523,157 |
26/24/26 | 125 | +0.48% | 761,747 |
25/24/25 | 124.4 | +1.02% | 454,643 |
Delayed Quote NSE India S.E., May 02, 2024 at 01:27 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+20.96% | 84.7M | |
+21.14% | 43.18B | |
+20.67% | 22.59B | |
+15.96% | 14.56B | |
+41.33% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- INDSWFTLAB Stock